top of page


Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic r
SC Ng, HY Shi, N Hamidi, FE Underwood, W Tang, EI Benchimol, R Panaccione, S Ghosh, JCY Wu, FK L Chan, JJY Sung, and GG Kaplan. Lancet. 2017. We performed a systematic review to assess the changing incidence and prevalence of inflammatory bowel disease around the world. At the turn of the 21st century, inflammatory bowel disease has become a global disease with accelerating incidence in newly industrialised countries. http://dx.doi.org/10.1016/S0140-6736(17)32448-0
Cancer Risk in 2,621 Chinese Patients with Inflammatory Bowel Disease: A Population- Based Cohort St
J So, W Tang, WK Leung, M Li, FH Lo, TL Wong, SF Sze, CM Leung, WC Tsang, HS Shan, KH Chan, CY Lam, AJ Hui, WH Chow, TY Lam, V Lam, TW Lee, HH Lo, CM Tang, CL Wong, JCY Wu, FKL Chan, JJY Sung, M Harbord, and SC Ng, In Press, 2017. [IF: 4.525] We conducted a population-based study to determine the risk of cancer in patients with Crohn's disease (CD) and ulcerative colitis (UC). We identified Two thousand six hundred twenty one patients with IBD (1108 CD; 1603 UC; median age, 4

Publications
Selected Journal Papers
bottom of page